Risks and benefits of current and novel drugs to treat agitation in Alzheimer’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risks and benefits of current and novel drugs to treat agitation in Alzheimer’s disease

Published:2022-10-03 Issue:10 Volume:21 Page:1289-1301
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Herrmann Nathan¹²,Wang Hui Jue¹³,Song Bing Xin¹³,Bawa Kritleen K.¹,Lanctôt Krista L.¹²³

Affiliation:

1. Department of Psychiatry, Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

2. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

3. Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada

Funder

Alzheimer’s Drug Discovery Foundation

Weston Brain Institute

Canadian Consortium on Neurodegeneration in Aging

Toronto Cannabis and Cannabinoid Research Consortium

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2136162

Reference72 articles.

1. Current understanding of Alzheimer’s disease diagnosis and treatment

2. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

3. 2020 Alzheimer's disease facts and figures

4. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

5. Behavioral and Psychological Symptoms of Dementia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis;Cellular and Molecular Neurobiology;2024-03-28

2. The Effect of Adding Mirtazapine to Quetiapine on Reducing Agitation in Patients with Alzheimer’s Disease;Journal of Alzheimer's Disease Reports;2024-01-29

3. Behavioral or neuropsychiatric symptoms of Alzheimer's disease: from psychopathology to pharmacological management;Arquivos de Neuro-Psiquiatria;2023-12

4. Cannabinoids as multifaceted compounds;Phytochemistry;2023-08

5. Effects of aromatherapy on agitation in patients with dementia in the community: A quasi-experimental study;Geriatric Nursing;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3